NCT01080014
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
- Locations
-
- Dr. Roberto Rosa Buenos Aires, Argentina
Clinical trial condition
Demyelinating Diseases
Explore clinical trials studying Demyelinating Diseases. Study availability and eligibility vary by location and protocol.
2,931 public trials
462 recruiting studies
Demyelinating Diseases trial results
NCT01080040
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Fundación Rosarina de Neurorehabilitación Rosario, Argentina
NCT01535664
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- OMRF Multiple Sclerosis Center of Excellence Oklahoma City, Oklahoma, United States
NCT00981084
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT00819195
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- UCSF Multiple Sclerosis Center San Francisco, California, United States
Completed
Modafinil in Multiple Sclerosis
NCT00142402
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +7 more
- Locations
-
- Kessler Foundation West Orange, New Jersey, United States
NCT00872053
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +9 more
- Locations
-
- Providence VA Medical Center Providence, Rhode Island, United States
NCT00156676
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Providence VA Medical Center Providence, Rhode Island, United States
Completed
Treatment Interruption of Natalizumab
NCT01071083
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +6 more
- Locations
-
- Research Site Cullman, Alabama, United States
- Research Site San Francisco, California, United States
- Research Site Fort Collins, Colorado, United States
- Research Site Pompano Beach, Florida, United States
NCT01108887
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Merck Serono Observational Site Breda, Netherlands